STAT

MARCH 4, 2024

Having Covid-19 increases a person’s risk of developing an autoimmune disease in the year after infection, a large study out of South Korea and Japan reports, but vaccination helps decrease that risk. Researchers used the medical records of 10 million Korean and 12 million Japanese adults to see whether those who had Covid were more likely to be diagnosed with autoimmune inflammatory rheumatic diseases, or AIRDs, in the year following infection.

Vaccines 364

Vaccines Medical Records 364

PharmaVoice

MARCH 4, 2024

In its zeal to stamp out anticompetitive practices and lower drug prices, a consultant said the FTC might have overlooked the unique considerations in rare disease drug development.

Drug Pricing 130

Drug Pricing Drug Development 130

STAT

MARCH 4, 2024

As a fetus develops, its body is bathed in amniotic fluid: a warm, salty soup of nutrients, hormones, and antibodies produced by its mother. And into that fluid, a fetus is constantly sloughing off or peeing out cells, which provide genetic material that doctors can pull out with a needle and examine for signs of disease in a process called amniocentesis.

356

356

PharmaVoice

MARCH 4, 2024

Why the company’s novel therapeutics could have a competitive edge in a crowded cancer indication.

147

147

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

MARCH 4, 2024

As part of its battle to blunt the growing cost of medicines, the White House on Monday held a so-called listening session in hopes of finding ways to rein in big pharmacy benefit managers, which occupy an opaque but crucial role in pharmaceutical pricing in the U.S. The gathering resembled something of a fact-finding mission as a small group of policymakers and business people briefly shared their experiences dealing with the largest industry middlemen, who negotiate with drugmakers on behalf o

354

354

pharmaphorum

MARCH 4, 2024

Inhaled cannabinoids have been shown to perform better than placebo in providing pain relief for people suffering from acute migraine in a clinical trial

145

145

The Pharmacist

MARCH 4, 2024

Following the Sigma Conference 2024, The Pharmacist sat down with Dr Leyla Hannbeck, chief executive of the Association of Independent Multiple Pharmacies (AIMp) to discuss how primary care can work together. How do you think AIMp members are approaching the idea of working collaboratively, with the different professions – including GPs? We've always felt this […] The post Leyla Hannbeck: We’ve got to work together as primary care appeared first on The Pharmacist.

114

114

STAT

MARCH 4, 2024

At first glance, the Coalition for Health AI looks like any technology lobbying group. Its membership — including Microsoft, Google, and many of the nation’s largest academic hospitals — forms a formidable presence in Washington. But on Monday, the coalition forged a different deal with federal regulators. It will work with them to develop quality and safety standards for artificial intelligence, an experiment that will test whether industry and government can effectively pa

Hospitals 352

Hospitals 352

BioPharma Dive

MARCH 4, 2024

The deal gives the German pharma partial rights to a closely watched medicine for transthyretin amyloidosis cardiomyopathy that analysts expect to become a multibillion-dollar product.

119

119

STAT

MARCH 4, 2024

Akero Therapeutics said Monday that extending treatment with its experimental drug for the liver disease known as MASH from six months to two years resulted in better outcomes for patients — most notably reductions in liver scarring at a rate three times higher than placebo without worsening other symptoms. The mid-stage study of the Akero drug called efruxifermin achieved its main goal in September 2022.

Drug Development 325

Drug Development 325

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Pharmaceutical Technology

MARCH 4, 2024

In late 2023, the Medicines and Healthcare products Regulatory Agency approved Vertex’s Casgevy, which became the inaugural clustered regularly interspaced short palindromic repeats (CRISPR)-based drug for the haematological indications beta thalassemia and sickle cell disease (SCD).

111

111

STAT

MARCH 4, 2024

Over the last few years, virtual mental health company Talkspace has been on a relentless quest to conquer the insurance market. The next step in that journey, Medicare, may prove the most challenging yet. Talkspace’s pivot away from its direct-to-consumer roots has so far been a success. The company claims its 130 million people have access to its services through deals with  insurers, employers, or through other arrangements, and it is now knocking on the door of profitability 

328

328

Express Pharma

MARCH 4, 2024

Attention-deficit/hyperactivity disorder (ADHD) is a clinically heterogenous neurodevelopmental disorder with high rates of comorbidity with other childhood-onset psychiatric disorders as well as learning disorders. As a result, pipeline products capable of targeting both ADHD and comorbid symptoms will have a competitive edge to capture a highly saturated ADHD market, says GlobalData.

111

111

STAT

MARCH 4, 2024

Lack of health data on LGBTQ+ people has real-world consequences. A participant in a 2020 report from the National LGBT Cancer Network said: “There are no guidelines for cancers that are more prevalent among Trans women. I had to fight like hell to have an anoscopy, and sure enough we found [precancerous lesions]!” That same year, the National Academies of Sciences, Engineering, and Medicine issued a hallmark report  on the health and well-being of LGBTQ+ people.

312

312

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Pharmafile

MARCH 4, 2024

Johnson & Johnson have announced that the US Food and Drug Administration (FDA) has approved Rybrevant (amibantamab-vmjw) following a priority review. The drug has been approved in combination with chemotherapy (carboplatin-pemetrexed) for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 […] The post FDA approves J&J’s Rybrevant with chemotherapy for NSCLC treatment appe

Chemotherapy 110

Chemotherapy 110

STAT

MARCH 4, 2024

A lot happens in the first month of human embryo development as a single cell morphs into multitudes. Yet despite its significance, this period is basically a “black box” to researchers, says stem cell biologist Jacob Hanna. He and his team at the Weizmann Institute of Science in Israel have taken steps toward probing that puzzle. Last year, they announced they had grown a synthetic human embryo , equivalent to a 14-day-old human embryo, in the lab without the aid of a human sperm

295

295

Express Pharma

MARCH 4, 2024

Dr Mansukh Mandaviya, Union Minister for Chemicals & Fertilizers and Health & Family Welfare virtually inaugurated 27 greenfield bulk drug park projects and 13 greenfield manufacturing plants for medical devices recently. Addressing the gathering, Dr Mandaviya said, “Medicines are an essential requirement for any society. During the COVID-19 pandemic, the dangers of supply chain getting affected, the risks of being highly dependent on imports of critical resources like bulk drugs and med

Compounding 105

Compounding 105

STAT

MARCH 4, 2024

WASHINGTON — The first over-the-counter birth control pill  will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin. Manufacturer Perrigo said Monday it has begun shipping the medication, Opill , to major retailers and pharmacies. A one-month supply will cost about $20 and a three-month supply will cost around $50, according to the company’s suggested retail price.

262

262

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

pharmaphorum

MARCH 4, 2024

Explore the future of drug manufacturing with dark factories, robotic and automated facilities that promise efficiency and innovation. Learn how these advancements are shaping a bright future for the pharmaceutical industry.

115

115

STAT

MARCH 4, 2024

A commonly prescribed medication for children’s asthma is disappearing from pharmacists’ shelves, forcing parents and pediatricians to scramble for alternatives just as  allergy seaso n  is about to start. In a move unusual for such a widely used drug, GlaxoSmithKline discontinued Flovent HFA, the brand name of its corticosteroid treatment fluticasone propionate, at the end of December.

286

286

The Pharmacist

MARCH 4, 2024

Perceptions of the safety of vaping have worsened considerably over the past decade amongst people who smoke, a UK study has found. The Cancer Research UK funded analysis has tracked survey responses since 2014 among more than 28,000 smokers in England. They found there had been an overall increase in the perceived harm of e-cigarettes […] The post Smokers’ views on harms of vaping worsened in recent years appeared first on The Pharmacist.

97

97

STAT

MARCH 4, 2024

SOMERVILLE — At 19 months old, Lucas Guo has never crawled, walked, or stood by himself. He babbles but can’t say words. He struggles to chew and swallow. He gets most of his nutrition through a feeding tube attached to his belly. Lucas has one of the world’s rarest diseases, ZTTK syndrome, a complex neurological disorder caused by a genetic mutation.

Documentation 262

Documentation 262

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

European Pharmaceutical Review

MARCH 4, 2024

As a cornerstone of advanced therapeutics in modern medicine, biologics command significant attention in the search for effective treatments for human diseases. These biopharmaceuticals encompass a range of products including vaccines, recombinant therapeutic proteins, tissues, cells and gene therapies – all sourced from living organisms. 1 However, the entry of biologics into the pharmaceutical market is not without unique challenges, particularly when compared to small molecule drugs.

Vaccines 98

Vaccines Immunity Immunization Compounding 98

STAT

MARCH 4, 2024

Next stop: Beacon Hill. Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative. But lawmakers so far are noncommittal on funding the plan.

246

246

European Pharmaceutical Review

MARCH 4, 2024

According to new data in older and heavier children treated with Novartis’ spinal muscular atrophy (SMA) gene therapy, nearly all participants in the Phase IIIb trial maintained or improved motor milestones after 52 weeks. Final data from the Phase IIIb SMART study of Zolgensma ® (onasemnogene abeparvovec) highlighted its safety and efficacy in children weighing ≥ 8.5kg to ≤ 21kg, with a mean age of 4.69 years.

Labelling 97

Labelling 97

STAT

MARCH 4, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello! A thought: I moved to San Diego last year and am always on the lookout for interesting news. If you’re here, reach out! In today’s newsletter, we discuss embryonic stem cell ethics, learn of parents searching for a treatment for their son’s ultra-rare neurological disease, and more.

Drug Pricing 262

Drug Pricing Drug Development 262

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

pharmaphorum

MARCH 4, 2024

The clock has started ticking in the EU on two marketing applications for AstraZeneca and Daiichi Sankyo’s TROP2-targeting antibody-drug conjugate datopotamab deruxtecan in breast and lung cancer. The EMA has validated the two parallel applications for the drug, also known as Dato-DXd, in adults with previously treated non-small cell lung cancer (NSCLC) and hormone receptor-positive, HER2-negative breast cancer.

113

113

Pharma Times

MARCH 4, 2024

Around 900,000 people in the UK are affected by the progressive neurodegenerative disease

126

126

Pharmaceutical Technology

MARCH 4, 2024

The EMA has validated the jointly developed TROP2-directed therapy for patients with breast or lung cancer following positive Phase III data.

103

103

Pharma Times

MARCH 4, 2024

In the UK alone, the aggressive form of cancer affects around 52,000 men every year

129

129

Express Pharma

MARCH 4, 2024

FLAME University hosted the annual conference of the Indian Drugs Manufacturers’ Association (IDMA) – vriddhi 2024, in association with Bain & Company on February 23-24. Held on its campus in Pune, the two-day conference welcomed over 40 business leaders, 50 organisations, investors, and policymakers, convening for a national summit. The agenda of this event was to examine and assess the opportunities, challenges, and strategic directions of the Indian pharma industry.

99

99